| Autor: |
N P Mitkovskaya, A O Konradi, Komarov Al, E I Tarlovskaya, Ye V Shlyakhto, V A Snezhitskiy, S V Malchikova, A I Chesnikova, L V Kolotsey, M M Petrova, A B Sugraliyev, V V Skibitsky, A G Arutyunov, N. A. Koziolova, Ya A Orlova, Tereshchenko Sn, Kropacheva Es, G P Arutyunov, I. V. Fomin, Yu N Belenkov, Panchenko Ep, I. S. Yavelov, Ardashev Av, I I Shaposhnik, N Yu Grigorieva, G A Dzhunusbekova, S G Kanorskii, A P Rebrov, Hamayak Sisakian, E G Zhelyakov, O. M. Drapkina |
| Rok vydání: |
2020 |
| Předmět: |
|
| Zdroj: |
Kardiologiia. 60:4-14 |
| ISSN: |
2412-5660
0022-9040 |
| Popis: |
This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific features of reversing heart rhythm disorders in patients with coronavirus infection and the interaction of antiarrhythmic and antiviral drugs. Recommendations are provided for outpatient and inpatient antithrombotic therapy for patients with COVID-19. Issues of antithrombotic and antiviral drug interaction are discussed. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
